Network-based analysis of disease-associated epigenetic changes in youth electronic cigarette users

The widespread use of electronic cigarettes (e-cigs) by youth is a significant public health problem in the US and
many parts of the world. To date, the long-term health effects of e-cig use in this vulnerable population are largely
unknown. Many toxicants and carcinogens present in e-cig vapor exert their biological effects through epigenetic
changes that can cause dysregulation of disease-related genes. Long non-coding RNAs (lncRNAs) are key
epigenetic regulators of gene expression in health and disease states.
Approach: To investigate lncRNA-mediated gene regulation and its association with disease development in
youth vapers, we will perform RNA-seq and network-based analyses on cells and tissues of youth e-cig users
as compared to non-users. Aim 1a: Using a systems biology approach, we will detect aberrant lncRNAs and
their interaction networks that drive gene dysregulation in youth e-cig users. The detected lncRNAs that govern
gene dysregulation in youth e-cig users can serve as novel biomarkers of exposure and effects for vaping. Aim
1b: Applying advanced prediction methods, we will identify which diseases are associated with the aberrant
lncRNAs detected in youth e-cig users. Aberrant lncRNAs in youth e-cig users that are associated with specific
diseases can be used for risk assessment of vaping. Aim 2: Using computational modeling, we will find the
associations between aberrant lncRNAs and the intensity and duration of vaping (i.e., dose) and the
characteristics of vaping products used by youth. Identifying product characteristics that influence the lncRNA-
mediated gene dysregulation in youth e-cig users can inform the FDA’s regulation of tobacco products to protect
youth and promote public health.
Responsiveness to RFA-OD-21-004: This proposal will maximize the use of existing biospecimens from our
recently completed NIDCR-funded project whose study subjects were recruited through collaboration with USC-
TCORS, which is sponsored by the FDA|CTP. This is a unique collection of biospecimens from a representative
sample of population in Southern California. No publicly available repository in the US offers similar specimens
needed for this proposal. We will generate scientific evidence on the health risks of e-cig use in youth, thus
informing the FDA’s regulation of tobacco products to protect this vulnerable population and promote public
health. We will use an innovative approach to address two scientific interest areas in this RFA, including
assessment of (1) exposure; and (2) potential harm from vaping in youth, who are a population of special
relevance. By elucidating the molecular changes that underlie the biological consequences of e-cig use in youth,
we will develop novel biomarkers of exposure and effects. These biomarkers will have significant utility for
assessing the health risks of e-cig use in this vulnerable population. By determining how vaping dose and product
characteristics can modulate the induced biological effects in youth e-cig users, we will provide urgently needed
data to inform the FDA’s regulation of tobacco products to protect youth and promote public health.

Grant Number: 5R21DA058342-02
NIH Institute/Center: NIH
Principal Investigator: AHMAD BESARATINIA